Γ-Hydroxyvaleric acid

γ-Hydroxyvaleric acid (GHV), also known as 4-methyl-GHB, is a designer drug related to γ-hydroxybutyric acid (GHB). It is sometimes seen on the grey market as a legal alternative to GHB, but with lower potency and higher toxicity,^[2] properties which have tended to limit its recreational use.^[3]

γ-Hydroxyvaleric acid

Clinical data
Other names	γ-Hydroxyvaleric acid GVB
Legal status
Legal status	US: DEA considers GHV a controlled substance analogue.[1] In general: uncontrolled
Identifiers
IUPAC name 4-Hydroxyvaleric acid
CAS Number	13532-37-1
PubChem CID	114539
ChemSpider	102591
UNII	58B139Q3RL
CompTox Dashboard (EPA)	DTXSID60928958
ECHA InfoCard	100.033.516
Chemical and physical data
Formula	C5H10O3
Molar mass	118.132 g·mol−1

γ-Valerolactone (GVL) acts as a prodrug to GHV, analogously to how γ-butyrolactone (GBL) is a prodrug to GHB.^[4]

See also

• 1,4-Butanediol (1-4-BD)
• Aceburic acid
• Valerenic acid
• Valeric acid